Literature DB >> 27052241

[Position statement: surgery and diabetes mellitus].

Peter Fasching1, Joakim Huber2, Martin Clodi3,4, Heidemarie Abrahamian5, Bernhard Ludvik6.   

Abstract

This position statement reflects the opinion of the Austrian Diabetes Association concerning the perioperative management of patients with diabetes mellitus based on the available scientific evidence. The paper covers necessary preoperative examinations from an internal/diabetological point of view as well as the perioperative metabolic control by means of oral antidiabetics and/or insulin therapy.

Entities:  

Keywords:  Consultation oral antidiabetics; Diabetes mellitus; Insulin therapy; Internal medicine; Metabolic control; Perioperative management; Surgery

Mesh：

Substances：

Year:  2016        PMID： 27052241     DOI： 10.1007/s00508-016-0982-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  14 in total

Review 1.  Clinical practice. Management of hyperglycemia in the hospital setting.

Authors:  Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2006-11-02       Impact factor: 91.245

Review 2.  Perioperative glycaemic control for diabetic patients undergoing surgery.

Authors:  Ana Maria Buchleitner; Montserrat Martínez-Alonso; Marta Hernández; Ivan Solà; Didac Mauricio
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  Diabetes and the Association of Postoperative Hyperglycemia With Clinical and Economic Outcomes in Cardiac Surgery.

Authors:  Giampaolo Greco; Bart S Ferket; David A D'Alessandro; Wei Shi; Keith A Horvath; Alexander Rosen; Stacey Welsh; Emilia Bagiella; Alexis E Neill; Deborah L Williams; Ann Greenberg; Jeffrey N Browndyke; A Marc Gillinov; Mary Lou Mayer; Jessica Keim-Malpass; Lopa S Gupta; Samuel F Hohmann; Annetine C Gelijns; Patrick T O'Gara; Alan J Moskowitz
Journal:  Diabetes Care       Date:  2016-01-19       Impact factor: 19.112

Review 4.  Blood glucose management in the patient undergoing cardiac surgery: A review.

Authors:  Pingle Reddy; Brian Duggar; John Butterworth
Journal:  World J Cardiol       Date:  2014-11-26

Review 5.  The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis.

Authors:  Kristin K Haga; Katie L McClymont; Scott Clarke; Rebecca S Grounds; Ka Ying B Ng; Daniel W Glyde; Robert J Loveless; Gordon H Carter; R Peter Alston
Journal:  J Cardiothorac Surg       Date:  2011-01-10       Impact factor: 1.637

6.  β-Blockade and Operative Mortality in Noncardiac Surgery: Harmful or Helpful?

Authors:  Mark L Friedell; Charles W Van Way; Ron W Freyberg; Peter L Almenoff
Journal:  JAMA Surg       Date:  2015-07       Impact factor: 14.766

Review 7.  Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Amr F Barakat; Marwan Saad; Ahmed Abuzaid; Amgad Mentias; Ahmed Mahmoud; Islam Y Elgendy
Journal:  Ann Thorac Surg       Date:  2016-02       Impact factor: 4.330

Review 8.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Authors:  Donald E G Griesdale; Russell J de Souza; Rob M van Dam; Daren K Heyland; Deborah J Cook; Atul Malhotra; Rupinder Dhaliwal; William R Henderson; Dean R Chittock; Simon Finfer; Daniel Talmor
Journal:  CMAJ       Date:  2009-03-24       Impact factor: 8.262

9.  Diabetes mellitus is associated with increased risk of surgical site infections: A meta-analysis of prospective cohort studies.

Authors:  Yu Zhang; Qiu-Jian Zheng; Sheng Wang; Shi-Xing Zeng; You-Ping Zhang; Xue-Jiao Bai; Tie-Ying Hou
Journal:  Am J Infect Control       Date:  2015-08       Impact factor: 2.918

Review 10.  Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis.

Authors:  Emily T Martin; Keith S Kaye; Caitlin Knott; Huong Nguyen; Maressa Santarossa; Richard Evans; Elizabeth Bertran; Linda Jaber
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-27       Impact factor: 3.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.